Veterinary Medicine Information website

DRONTAL JUNIOR, Perorální suspenze

Authorised
  • Febantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
DRONTAL JUNIOR, Perorální suspenze
Active substance:
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog (puppy)
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    15.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyrantel embonate
    14.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC55
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/1158/97-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download